291 related articles for article (PubMed ID: 26501907)
21. Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice.
Kim AL; Labasi JM; Zhu Y; Tang X; McClure K; Gabel CA; Athar M; Bickers DR
J Invest Dermatol; 2005 Jun; 124(6):1318-25. PubMed ID: 15955110
[TBL] [Abstract][Full Text] [Related]
22. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
[TBL] [Abstract][Full Text] [Related]
23. Involvement of p38 MAP kinase in lipopolysaccharide-induced production of pro- and anti-inflammatory cytokines and prostaglandin E(2) in human choriodecidua.
Shoji T; Yoshida S; Mitsunari M; Miyake N; Tsukihara S; Iwabe T; Harada T; Terakawa N
J Reprod Immunol; 2007 Oct; 75(2):82-90. PubMed ID: 17617469
[TBL] [Abstract][Full Text] [Related]
24. Strong inhibition of TNF-alpha production and inhibition of IL-8 and COX-2 mRNA expression in monocyte-derived macrophages by RWJ 67657, a p38 mitogen-activated protein kinase (MAPK) inhibitor.
Westra J; Doornbos-van der Meer B; de Boer P; van Leeuwen MA; van Rijswijk MH; Limburg PC
Arthritis Res Ther; 2004; 6(4):R384-92. PubMed ID: 15225374
[TBL] [Abstract][Full Text] [Related]
25. High-throughput automated confocal microscopy imaging screen of a kinase-focused library to identify p38 mitogen-activated protein kinase inhibitors using the GE InCell 3000 analyzer.
Trask OJ; Nickischer D; Burton A; Williams RG; Kandasamy RA; Johnston PA; Johnston PA
Methods Mol Biol; 2009; 565():159-86. PubMed ID: 19551362
[TBL] [Abstract][Full Text] [Related]
26. Distinct role of MAPKAPK-2 in the regulation of TNF gene expression by Toll-like receptor 7 and 9 ligands.
Thuraisingam T; Xu YZ; Moisan J; Lachance C; Garnon J; Di Marco S; Gaestel M; Radzioch D
Mol Immunol; 2007 Jul; 44(14):3482-91. PubMed ID: 17485113
[TBL] [Abstract][Full Text] [Related]
27. Low-molecular-weight MK2 inhibitors: a tough nut to crack!
Schlapbach A; Huppertz C
Future Med Chem; 2009 Oct; 1(7):1243-57. PubMed ID: 21426101
[TBL] [Abstract][Full Text] [Related]
28. Activation of multiple proline-directed kinases by bacterial lipopolysaccharide in murine macrophages.
Sanghera JS; Weinstein SL; Aluwalia M; Girn J; Pelech SL
J Immunol; 1996 Jun; 156(11):4457-65. PubMed ID: 8666821
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of N-cyclopropylbenzamide-benzophenone hybrids as novel and selective p38 mitogen activated protein kinase (MAPK) inhibitors.
Heo J; Shin H; Lee J; Kim T; Inn KS; Kim NJ
Bioorg Med Chem Lett; 2015 Sep; 25(17):3694-8. PubMed ID: 26115577
[TBL] [Abstract][Full Text] [Related]
30. Mitogen-activated protein kinase activated protein kinase 2 (MK2) participates in p38 MAPK regulated control of oligodendrocyte differentiation.
Haines JD; Fang J; Mushynski WE; Almazan G
Glia; 2010 Aug; 58(11):1384-93. PubMed ID: 20607863
[TBL] [Abstract][Full Text] [Related]
31. Acute lymphoid and gastrointestinal toxicity induced by selective p38alpha map kinase and map kinase-activated protein kinase-2 (MK2) inhibitors in the dog.
Morris DL; O'Neil SP; Devraj RV; Portanova JP; Gilles RW; Gross CJ; Curtiss SW; Komocsar WJ; Garner DS; Happa FA; Kraus LJ; Nikula KJ; Monahan JB; Selness SR; Galluppi GR; Shevlin KM; Kramer JA; Walker JK; Messing DM; Anderson DR; Mourey RJ; Whiteley LO; Daniels JS; Yang JZ; Rowlands PC; Alden CL; Davis JW; Sagartz JE
Toxicol Pathol; 2010 Jun; 38(4):606-18. PubMed ID: 20448081
[TBL] [Abstract][Full Text] [Related]
32. 4-Anilino-6-phenyl-quinoline inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK2).
Olsson H; Sjö P; Ersoy O; Kristoffersson A; Larsson J; Nordén B
Bioorg Med Chem Lett; 2010 Aug; 20(16):4738-40. PubMed ID: 20643547
[TBL] [Abstract][Full Text] [Related]
33. Mitogen-activated protein kinase-activated protein kinase-2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer.
Morgan D; Berggren KL; Spiess CD; Smith HM; Tejwani A; Weir SJ; Lominska CE; Thomas SM; Gan GN
Mol Carcinog; 2022 Feb; 61(2):173-199. PubMed ID: 34559922
[TBL] [Abstract][Full Text] [Related]
34. Role of p38 MAPK in LPS induced pro-inflammatory cytokine and chemokine gene expression in equine leukocytes.
Neuder LE; Keener JM; Eckert RE; Trujillo JC; Jones SL
Vet Immunol Immunopathol; 2009 Jun; 129(3-4):192-9. PubMed ID: 19070370
[TBL] [Abstract][Full Text] [Related]
35. Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: ménage à trois or ménage à quatre?
Shiryaev A; Moens U
Cell Signal; 2010 Aug; 22(8):1185-92. PubMed ID: 20227494
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase.
Chopra P; Kulkarni O; Gupta S; Bajpai M; Kanoje V; Banerjee M; Bansal V; Visaga S; Chatterjee M; Chaira T; Shirumalla RK; Verma AK; Dastidar SG; Sharma G; Ray A
Int Immunopharmacol; 2010 Apr; 10(4):467-73. PubMed ID: 20093202
[TBL] [Abstract][Full Text] [Related]
37. 2-Acylaminopyridin-4-ylimidazoles as p38 MAP kinase inhibitors: Design, synthesis, and biological and metabolic evaluations.
Ziegler K; Hauser DR; Unger A; Albrecht W; Laufer SA
ChemMedChem; 2009 Nov; 4(11):1939-48. PubMed ID: 19731280
[TBL] [Abstract][Full Text] [Related]
38. MK2: a novel molecular target for anti-inflammatory therapy.
Duraisamy S; Bajpai M; Bughani U; Dastidar SG; Ray A; Chopra P
Expert Opin Ther Targets; 2008 Aug; 12(8):921-36. PubMed ID: 18620516
[TBL] [Abstract][Full Text] [Related]
39. p38 MAPK signalling regulates cytokine production in IL-33 stimulated Type 2 Innate Lymphoid cells.
Petrova T; Pesic J; Pardali K; Gaestel M; Arthur JSC
Sci Rep; 2020 Feb; 10(1):3479. PubMed ID: 32103032
[TBL] [Abstract][Full Text] [Related]
40. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
